THE USE of hypoxic cell sensitizers in improving the therapeutic ratio is the subject of much experimental and clinical investigation. Unfortunately the most widely used compound, misonidazole (MISO) increases the number of treatment complications, in particular causing peripheral neuropathies (Dische et al., 1978) . It is also found in the laboratory that MISO enhances the effect of radiation on some normal tissues. Hendry & Sutton (1978) argued from experiments with hyperbaric 02 or MISO that at least some normal tissues contain a significant proportion of hypoxic cells, which should be taken into account in treatment with hypoxic cell sensitizers. It is natural to be especially cautious of radiosensitization in tissue in which direct drug toxicity has been observed, i.e. the central nervous system. Recently Yuhas (1 979) reported the results of a pilot study in which 0-2 mg/g MISO given to rats caused an increase in the incidence of paralysis due to irradiation of a segment of the spinal cord. The sensitizer enhancement ratio (SER) in these experiments was about 1P3 though the data were rather limited. However, more extensive experiments of a similar nature have been performed by van der Kogel (personal communication) on anaesthetized rats, and he found no enhanced radiation response of the spinal cord.
Clearly, the effects of radiosensitizing drugs on the CNS need further investigation. A convenient method for estimatingradiation damage to neuroglia is by counting cells in the subependymal layer of the rodent forebrain. In the rat these cells divide Accepte(1 3 MIarchi 1981 throughout life, adding to the glial population (Lewis, 1968; Hopewell, 1971 ) but their precise role in the development of late radiation damage to the brain is unclear. The method has been used by Chauser et al. (1977) to estimate neutron RBE for brain damage, and in the present report the same technique has been used to measure the SER for MISO Female CFHB albino rats, aged 8 weeks, were anaesthetized with 75 mg/kg amylobarbitone sodium in saline. Animals were irradiated with a horizontal beam in air at room temperature with 250 kVp X-rays (HVL 1-3mm Cu) at a dose rate of 1P77 Gy/min. A 3cm diameter field size was used to treat an area from the front of the ear base to the back of the eye and above the oropharynx. The dosimetry was checked by means of lithium fluoride rods inside the brain of dead rats, and calibrated against a Farmer-Baldwin ionization chamber.
A range of single doses from 2 5 to 15 G;y was used. The control rats were shamirradiated. Four animals per dose received radiation alone and 4 were given 1 mg/g body weight of MISO dissolved in a warm solution of saline (30 mg/ml) and injected i.p. 45 min before irradiation. The rats were killed 30 days later, and perfused with formal saline via the left ventricle. The brain was removed whole and divided by a horizontal section through the lateral ventricles at the level B-B1 (Zeman & Innes, . This was achieved by means of a special Perspex jig constructed with a fixed guillotine. The brains were fixed for a further week, then The drug alone at 10 mg/g caused no reduction in the number of subependymal plate cells at 30 days. Irradiation caused a reduction in cell number, but MISO had no effect on the radiation response.
There have been a number of investigations into the radiosensitizing effects of MISO on experimental normal tissues. Values obtained with 1 mg/g of the drutg in single treatments range from 1-0 to 16 (Table) . In clinical use a serum concentration in man of 100 mg/ml is rarely exceeded. This concentration is achieved in rodents by giving 04I mg/g body weight, which would give a drug enhancement of about half that from 1 mg/g (Hendry & Sutton, personal comm.) . Thus the maximum likely enhancement in man is about one half the values obtained in rodents using 1 mg/g of the drug. But even with a drug dose of 0 1 mg/g and giving 10 fractions of drug and radiation to mouse feet a 10% enhancement in skin has been demonstrated (Stewart, 1980) . This treatment is a reasonable approximation to the clinical situation. Thus the presence of hypoxic cells in some normal tissues and their sensitization by MISO certainly cannot be ignored. Whether or not the CNS is well oxygenated is not certain, though the indications are slightly in favour of a small proportion of hypoxic cells, especially in anaesthetized animals (Zeman, 1977; van AutlioIrs Stewart, 1980 Stewart, 1980 Yuhas, 1979 Yuhas et at., Yuhas et at., 1977 Yuhas et a1l., 1977 Stewart, 1980 Brown, 1975 Suzuki et (l., 1977 Hopewell & Wright, 1969; Asbell & Kramer, 1971) . It is known that MISO crosses the bloodbrain barrier, and recently Brown & Workman (1980) have demonstrated in mice a brain/plasma ratio of MISO, measured 18-75 min after administration of the drug, not different from 1 0. This demonstrates convincingly that the drug is not excluded from the brain. However, in our experiments there was no detectable effect of MISO, either as direct toxicity or as enhanced radiosensitivity, on the cells in the subependymal layer of rat brain. These are clearly of importance, and certainly exist in man, though their activity decreases with age. It appears, therefore, from the lack of sensitization by MISO, that there is not a significant proportion of hypoxic subependymal-plate cells. This result is also relevant to the effects of neutron irradiation to the brain, which has a relatively high RBE, suggesting that this is due to intrinsic cellular factors rather than hypoxia (Chauser et al., 1977) .
